Scutellarin : Scutellarin ameliorates nonalcoholic fatty liver disease through the PPAR/PGC-1-Nrf2 pathway
SNS-032 : Interactions of cyclin‑dependent kinase inhibitors AT‑7519, flavopiridol and SNS‑032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
Mifepristone : Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology
BVD-523 : Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics
Trastuzumab : Systemic Therapy of Central Nervous System Metastases of Breast Cancer
Glycochenodeoxycholic acid : The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin
TPH104m: Data of expression status of miR- 29a and its putative target mitochondrial apoptosis regulatory gene DRP1 upon miR-15a and miR-214 inhibition
EIDD-2801: Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
INCB024360 : Tumor microenvironment-responsive prodrug nanoplatform via co-self- assembly of photothermal agent and IDO inhibitor for enhanced tumor penetration and cancer immunotherapy